ArticleNeurology(R) neuroimmunology & neuroinflammation2022

Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod.

Virginia Palomares Cabeza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.